Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery.

[1]  M. Stafford-Smith,et al.  The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. , 2006, Anesthesia and analgesia.

[2]  M. Falagas,et al.  Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  L. McMahon,et al.  Contribution of infection to increased mortality in women after cardiac surgery. , 2006, Archives of internal medicine.

[4]  A. Jacobs,et al.  Women, ischemic heart disease, revascularization, and the gender gap: what are we missing? , 2006, Journal of the American College of Cardiology.

[5]  B. Lytle,et al.  Transfusion increases the risk of postoperative infection after cardiovascular surgery. , 2006, Journal of the American College of Surgeons.

[6]  N. Blumberg.  Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt , 2005, Transfusion.

[7]  G. Ortolano,et al.  Universal Leukocyte Reduction: Is It Appropriate Medical Practice or Not? , 2005, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[8]  D. Katritsis,et al.  Does leukofiltration reduce pulmonary infections in CABG patients? A prospective, randomized study with early results and mid-term survival , 2005, Acta cardiologica.

[9]  E. L. Wallace,et al.  Blood collection and transfusion in the United States in 1999 , 2005, Transfusion.

[10]  P. Marik,et al.  Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. , 2005, Chest.

[11]  Z. Ali,et al.  Allogenic blood transfusion does not predispose to infection after cardiac surgery. , 2004, The Annals of thoracic surgery.

[12]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[13]  D. Fergusson,et al.  Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  Chris A Rogers,et al.  Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency , 2004, The Lancet.

[15]  L. Goodnough.  Risks of blood transfusion. , 2005, Critical care medicine.

[16]  Nnis System.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[17]  P. Glass,et al.  Blood Use in Patients Undergoing Coronary Artery Bypass Surgery: Impact Of Cardiopulmonary Bypass Pump, Hematocrit, Gender, Age, and Body Weight , 2003, Anesthesia and analgesia.

[18]  Lawrence J Saidman,et al.  Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgery. , 2003, Journal of cardiothoracic and vascular anesthesia.

[19]  Clifford Goodman,et al.  Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment—final report , 2003, Transfusion.

[20]  E. Vamvakas,et al.  WBC‐containing allogeneic blood transfusion and mortality: a meta‐analysis of randomized controlled trials , 2003, Transfusion.

[21]  J. Minei,et al.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2002, The Journal of trauma.

[22]  Robert W. Taylor,et al.  Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient* , 2002, Critical care medicine.

[23]  J Benichou,et al.  A review of adjusted estimators of attributable risk , 2001, Statistical methods in medical research.

[24]  N. Powe,et al.  Validating billing data for RBC transfusions: a brief report , 2001, Transfusion.

[25]  E. Vamvakas,et al.  Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? , 2001, Blood.

[26]  J. Marshall,et al.  Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.

[27]  P. Holland,et al.  Universal leukocyte reduction , 2000, Current opinion in hematology.

[28]  J. Maessen,et al.  Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. , 1999, Chest.

[29]  W. Vaughn,et al.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome , 1999, Transfusion.

[30]  R. P. Falcão,et al.  The effect of unmodified or prestorage white cell‐reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients , 1999, Transfusion.

[31]  M. Kanter,et al.  Transfusion medicine. First of two parts--blood transfusion. , 1999, The New England journal of medicine.

[32]  J. Hermans,et al.  Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. , 1998, Circulation.

[33]  S. Body,et al.  Variability in Transfusion Practice for Coronary Artery Bypass Surgery Persists Despite National Consensus Guidelines: A 24‐Institution Study , 1998 .

[34]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[35]  M. Hokland,et al.  A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery , 1996, The British journal of surgery.

[36]  G. Hicks,et al.  Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. , 1992, The Journal of thoracic and cardiovascular surgery.